Wall Street Analysts Predict a 49.89% Upside in CareDx (CDNA): Here's What You Should Know

Core Viewpoint - CareDx (CDNA) shows potential for significant upside, with a mean price target of $34.67 indicating a 49.9$23.13 [1] Price Targets - The average price target consists of six estimates ranging from a low of $28 to a high of$40, with a standard deviation of $4.97, suggesting a consensus among analysts [2] - The lowest estimate indicates a 21.1% increase, while the highest suggests a 72.9% upside [2] Analyst Sentiment - Analysts exhibit strong agreement on CDNA's ability to report better earnings than previously predicted, which supports the expectation of stock upside [4] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 15.7%, with three estimates moving higher and no negative revisions [10] Zacks Rank - CDNA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [11] Earnings Estimate Revisions - There is a strong correlation between trends in earnings estimate revisions and near-term stock price movements, suggesting that the positive revisions could lead to stock price increases [9]